McKesson Backs Away From A Mega-Acquisition
In case you didn’t notice, McKesson (NYSE:MCK) appears to have taken the possibility of a mega-acquisition off the table with two recent announcements about its cash hoard:
McKesson ended the first calendar quarter of 2010 with $3.7 billion in cash but only $2.3 billion in long-term debt. (See chart below.) This cash mountain suggests McKesson had plenty of room to take on more debt and swing a major acquisition. A big acquisition is still possible, but just less likely.
I wrote about the Phoenix Group option in Is McKesson in the hunt for an EU acquisition? The Merckle family, who owns Phoenix, made a bundle off the sale of Ratiopharm to Teva and therefore lost the compelling need to sell the European wholesaler.
A Wall Street Journal article written at the peak of the buyback boom of 2007 suggests three reasons for buybacks.
- Buybacks are a tax-efficient way to return cash to shareholders. Dividends are taxable but there is no tax due on a share buyback unless investors sell their shares.
- Buybacks signal that the company doesn’t know how to grow.
- Buybacks can benefit corporate executives, especially if their compensation is tied to Earnings Per Share and share-price targets. Buybacks also benefit executives with large holdings of stock options.
I prefer not to speculate on McKesson's motivations on the blog, so I leave it to the Wall Street boffins to sort out the relative merits of these explanations.
I have to ask; Where did you get that picture of cash? As always i enjoy reading your blog.
ReplyDeleteNoah
Contract Pharmacy Services
Google Image Search
ReplyDeleteTruth be told, I spend an embarrassing amount of time trying to find suitable photo accompaniment for my blog posts.
Adam
I recently found your site,
ReplyDeleteI enjoy reading the information you present.
As some of us know education is the biggest obstacle in moving these business forward.
Best wishes in Orlando.
Robert.